Cytokinetics (CYTK) Misses Q3 EPS by 59c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $67.56 -1.77%
EPS Growth %: +43.1%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +43.1%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($1.35), $0.59 worse than the analyst estimate of ($0.76).
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Credo Technology shares rise on analyst support and conference comments
- Endava CFO placed on leave amid accounting probe
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
